Protein kinase C modulates receptor-independent activation of endothelial nitric oxide synthase.
The intracellular regulation of nitric oxide synthase has been the focus of intense investigation. Bioassay studies using vascular rings have suggested that protein kinase C inhibits endothelium-dependent vascular relaxation. However, information regarding the effects of protein kinase C on the synthesis of nitric oxide in endothelial cells is not available. Therefore, we investigated the effects of protein kinase C to regulate receptor-independent activation of nitric oxide synthase activity in cultured bovine pulmonary artery endothelial cells. Activation of protein kinase C by phorbol 12-myristate 13-acetate or 1,2-dioctanoyl-sn-glycerol inhibited receptor-dependent and receptor-independent nitric oxide synthase activity. The inhibition of nitric oxide synthase by protein kinase C was concentration dependent and markedly blunted by staurosporine. The inhibition of protein kinase C by staurosporine alone enhanced basal nitric oxide synthase activity. Furthermore, depletion of protein kinase C enhanced both basal and agonist-stimulated nitric oxide synthase activity. These studies indicate that protein kinase C modulates the activity of the constitutive Ca2+/calmodulin-dependent endothelial nitric oxide synthase in the basal state and following agonist stimulation through direct inhibition of the enzyme as well as receptor desensitization. These direct regulatory effects of protein kinase C on endothelial nitric oxide synthase activity may have important implications in the physiologic regulation of vascular tone.
Davda
R K
RK
Division of Nephrology, Hypertension and Transplantation, University of Florida College of Medicine, Gainesville.
Chandler
L J
LJ
Guzman
N J
NJ
D000470:Alkaloids / Q000494:pharmacology; D000594:Amino Acid Oxidoreductases / Q000378:metabolism*; D000818:Animals; D002417:Cattle; D002478:Cells, Cultured; D004075:Diglycerides / Q000494:pharmacology; D004730:Endothelium, Vascular / Q000201:enzymology*; D004789:Enzyme Activation / Q000187:drug effects; D019001:Nitric Oxide Synthase; D011493:Protein Kinase C / Q000037:antagonists & inhibitors / Q000378:metabolism*; D011651:Pulmonary Artery; D019311:Staurosporine; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D000470:Alkaloids; D004075:Diglycerides; C044295:1,2-dioctanoylglycerol; D019001:Nitric Oxide Synthase; D000594:Amino Acid Oxidoreductases; D011493:Protein Kinase C; D019311:Staurosporine; D013755:Tetradecanoylphorbol Acetate